Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled loxapine for acute agitation in schizophrenia or bipolar disorder
CTR20192234Phase 3Completed
- Sponsor
- Zhaoke Pharmaceutical (Hefei) Co., Ltd.
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of loxapine in schizophrenia, bipolar disorder (BD), agitation, sponsored by Zhaoke Pharmaceutical (Hefei) Co., Ltd.. Started Mar 2020; status: completed.
02
Drugs
loxapine
03
Conditions
schizophreniabipolar disorder (BD)agitation
Beyond the preview
Go deeper on CTR20192234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192234.